Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.

Ying Liu, Danyang Li, Qingxin Xia et al.|Journal of Clinical Oncology|2021

Cited by 36